| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |